Loading organizations...
Loading organizations...
Biotech company accelerating drug discovery using AI/ML and wet-lab data.
Biolexis Therapeutics has raised $10.0M across 1 funding round.
Biolexis Therapeutics has raised $10.0M in total across 1 funding round.
Biolexis Therapeutics has raised $10.0M in total across 1 funding round.
Biolexis Therapeutics's investors include James Clarke.
Biolexis Therapeutics has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in December 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 6, 2023 | $10.0M Series A | James Clarke, James Clarke |